Your session is about to expire
← Back to Search
Hemodialysis for Chronic Kidney Failure
N/A
Waitlist Available
Led By Tammy Sirich, MD
Research Sponsored by Palo Alto Veterans Institute for Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial will see if patients with some kidney function will do better with two hemodialysis treatments a week, instead of the usual three.
Who is the study for?
This trial is for stable dialysis patients who can consent to participate. It's not for those who've used antibiotics in the last two months, expect to use them soon, were recently hospitalized, or have very low residual kidney function (<2.5 mL/min).
What is being tested?
The study compares the effectiveness of hemodialysis twice a week versus the standard three times a week in patients who still have some kidney function left.
What are the potential side effects?
Potential side effects may include cramping, low blood pressure during treatment, fatigue after sessions, and possible changes in remaining kidney function.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
QOL: KDQOL36
Secondary study objectives
Cognition
Solute Concentration
Symptom
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Twice weekly hemodialysisExperimental Treatment1 Intervention
Participants will undergo hemodialysis twice per week.
Group II: Thrice weekly hemodialysisExperimental Treatment1 Intervention
Participants will undergo hemodialysis three times per week.
Find a Location
Who is running the clinical trial?
Palo Alto Veterans Institute for ResearchLead Sponsor
55 Previous Clinical Trials
8,302 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,439 Previous Clinical Trials
4,324,774 Total Patients Enrolled
Tammy Sirich, MDPrincipal Investigator - Stanford/VA Palo Alto Health Care System
Palo Alto Veterans Institute for Research
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have taken antibiotics in the last two months or are expected to take them during the study.You recently had a hospital stay or another event that made it hard for you to eat regularly.Your kidneys are not working well, and filter less than 2.5 milliliters of fluid per minute.
Research Study Groups:
This trial has the following groups:- Group 1: Twice weekly hemodialysis
- Group 2: Thrice weekly hemodialysis
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger